Dainippon, Edison Sign Deal For R&D On Mitochondria Drugs
This article was originally published in PharmAsia News
Executive Summary
Dainippon Sumitomo Pharma and Edison Pharmaceuticals have signed an agreement to co-develop drugs based on mitochondria, the parts of cells involved in regulating their activity.